Skip to Content

THIS END UP RDY 532 (Divalproex Sodium Delayed-Release (Sprinkle) 125 mg)

Pill with imprint THIS END UP RDY 532 is Blue & White, Capsule-shape and has been identified as Divalproex Sodium Delayed-Release (Sprinkle) 125 mg. It is supplied by Dr. Reddy’s Laboratories Inc..

Divalproex sodium is used in the treatment of bipolar disorder; epilepsy; mania; migraine prevention; borderline personality disorder (and more), and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 125 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for THIS END UP RDY 532

Divalproex sodium delayed-release (sprinkle) 125 mg THIS END UP RDY 532
Divalproex sodium delayed-release (sprinkle) 125 mg THIS END UP RDY 532
Divalproex sodium delayed-release (sprinkle) 125 mg THIS END UP RDY 532 Front
Divalproex sodium delayed-release (sprinkle) 125 mg THIS END UP RDY 532 Back
Divalproex sodium delayed-release (sprinkle) 125 mg THIS END UP RDY 532

Divalproex Sodium Delayed-Release (Sprinkle)

Imprint:
THIS END UP RDY 532
Strength:
125 mg
Color:
Blue & White
Size:
19.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Fatty acid derivative anticonvulsants
Pregnancy Category:
D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder
X - Not for use in pregnancy - When treating migraine
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Dr. Reddy’s Laboratories Inc.
Inactive Ingredients:
ferrosoferric oxide
D&C Red No. 28
FD&C Blue No. 1
ethylcelluloses
gelatin
hypromelloses
magnesium stearate
raw sugar
titanium dioxide
triethyl citrate
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide